---
figid: PMC7970221__gr1
figtitle: Bioactive nanotherapeutic trends to combat triple negative breast cancer
organisms:
- Homo sapiens
- Mus musculus
- Equus caballus
- Mouse mammary tumor virus
- Ithyoclinostomum yamagutii
pmcid: PMC7970221
filename: gr1.jpg
figlink: /pmc/articles/PMC7970221/figure/fig1/
number: F1
caption: Schematic illustration of various treatment strategies for TNBC. Conventional
  strategies with chemotherapeutic agents (doxorubicin, paclitaxel, and cisplatin),
  targeted strategies includes specific pathway inhibitors, immunotherapies, and nanotechnology
  (drug loaded nanoparticles or antibody drug conjugates).
papertitle: Bioactive nanotherapeutic trends to combat triple negative breast cancer.
reftext: Pallabita Chowdhury, et al. Bioact Mater. 2021 Oct;6(10):3269-3287.
year: '2021'
doi: 10.1016/j.bioactmat.2021.02.037
journal_title: Bioactive Materials
journal_nlm_ta: Bioact Mater
publisher_name: KeAi Publishing
keywords: Breast cancer treatment | Triple negative breast cancer | Chemotherapy |
  Nanoparticles | Membrane cloaked nanoparticles | Nanomedicine | Biomimetic nanoparticles
automl_pathway: 0.7627584
figid_alias: PMC7970221__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Equus caballus
- Homo sapiens
redirect_from: /figures/PMC7970221__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7970221__gr1.html
  '@type': Dataset
  description: Schematic illustration of various treatment strategies for TNBC. Conventional
    strategies with chemotherapeutic agents (doxorubicin, paclitaxel, and cisplatin),
    targeted strategies includes specific pathway inhibitors, immunotherapies, and
    nanotechnology (drug loaded nanoparticles or antibody drug conjugates).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Parp1
  - Ar
  - Cdk4
  - Cdk6
  - Pik3r1
  - Akt1
  - Gadl1
  - Azin2
  - Nano
  - Cd274
  - Ctla4
  - AR
  - CDK4
  - CDK6
  - AZIN2
  - CTLA4
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - GADL1
  - CD274
---
